Research Papers:

A TET2 rs3733609 C/T genotype is associated with predisposition to the myeloproliferative neoplasms harboring JAK2V617F and confers a proliferative potential on erythroid lineages

Xiao-hui Shen, Nan-nan Sun, Ya-fei Yin, Su-fang Liu, Xiao-liu Liu, Hong-ling Peng, Chong-wen Dai, Yun-xiao Xu, Ming-yang Deng, Yun-ya Luo, Wen-li Zheng and Guang-sen Zhang _

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:9550-9560. https://doi.org/10.18632/oncotarget.7072

Metrics: PDF 2062 views  |   HTML 2035 views  |   ?  


Xiao-hui Shen1, Nan-nan Sun1, Ya-fei Yin1, Su-fang Liu1, Xiao-liu Liu1, Hong-ling Peng1, Chong-wen Dai1, Yun-xiao Xu1, Ming-yang Deng1, Yun-ya Luo1, Wen-li Zheng1, Guang-sen Zhang1

1Division of Hematology, Institute of Molecular Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, P.R. China

Correspondence to:

Guang-sen Zhang, e-mail: [email protected]

Keywords: myeloproliferative neoplasms, TET2, rs3733609, clinical significance, mechanisms

Received: August 19, 2015     Accepted: January 13, 2016     Published: January 29, 2016


Common germline single-nucleotide polymorphisms (SNPs) at JAK2 locus have been associated with Myeloproliferative neoplasms (MPN). And, the germline sequence variant rs2736100 C in TERT is related to risk of MPN, suggesting a complex association between SNPs and the pathogenesis of MPN. Our previous study (unpublished data) showed that there was a high frequency distribution in rs3733609 C/T genotype at Ten-Eleven Translocation 2 (TET2) locus in one Chinese familial primary myelofibrosis. In the present study, we evaluate the role and clinical significance of rs3733609 C/T genotype in JAK2V617F-positive sporadic MPN (n = 181). TET2 rs3733609 C/T genotype had a higher incidence (13.81%; 25/181) in JAK2V617F-positive sporadic MPN patients than that in normal controls (n = 236) (6.35%; 15/236), which was predisposing to MPN (odds ratio(OR) = 2.361; P = 0.01). MPN patients with rs3733609 C/T genotype had increased leukocyte and platelets counts, elevated hemoglobin concentration in comparison with T/T genotype. Thrombotic events were more common in MPN patients with rs3733609 C/T than those with T/T genotype (P < 0.01). We confirmed that rs3733609 C/T genotype downregulated TET2 mRNA transcription, and the mechanism may be involved in a disruption of the interaction between CCAAT/enhancer binding protein alpha (C/EBPA) and TET2 rs3733609 C/T locus.TET2 rs3733609 C/T genotype stimulated the erythroid hematopoiesis in MPN patients. Altogether, we found a novel hereditary susceptible factor-TET2 rs3733609 C/T variant for the development of MPN, suggesting the variant may be partially responsible for the pathogenesis and accumulation of MPN.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7072